The Agrobacterium genus is most widely recognized as a collection of prominent plant pathogens (11, 12) . These organisms are distributed throughout the environment, including soil, and are typically oxidase positive, aerobic, motile, non-spore-forming gram-negative rods that resemble CDC group Vd-3 (19) . All Agrobacterium species except A. radiobacter induce neoplastic growth in a variety of plants after traumatic inoculation into the plant tissue (11, 12) . The phytopathogenicity of Agrobacterium species is conferred by a 100-to 160-megadalton plasmid called the Ti plasmid (12) . Except for the absence of this plasmid, A. radiobacter is biochemically indistinguishable from A. tumefaciens and, therefore, is likely a single species.
Agrobacteria are infrequently observed in the clinical microbiology laboratory and rarely cause human infection. Prior to this report, only 18 cases of true Agrobacterium infection in humans (i.e., excluding theAgrobacterium "yellow group") have appeared in the literature. All but two occurred in patients with transcutaneous catheters or implanted biomedical prostheses, and only a single isolate was reported asAgrobacterium radiobacter biovar 2 (9) . None of the previously reported clinical isolates of Agrobacterum species were characterized as mucoid strains. We report here a mucoid phenotype of Agrobacterium radiobacter biovar 2 recovered from an immunocompromised child with bacteremia.
A 3½2-year-old boy undergoing treatment for a primitive neuroectodermal tumor of the brain was admitted to Texas Children's Hospital in February 1992 for evaluation of fever and sepsis. The child's illness had been diagnosed in March 1990, at which time he underwent partial resection of the tumor followed by chemotherapy, irradiation, and an autologous bone marrow transplantation. A recurrence of the tumor was discovered in September 1991, and he underwent * Corresponding author. a second resection with placement of a ventriculo-peritoneal shunt, a central venous catheter, and additional therapy with carboplatin and etoposide. In November 1991, the child developed a shunt infection and peritoneal abscess caused by Streptococcus sanguis and Staphylococcus epidermidis that necessitated drainage of the abscess, shunt removal and replacement, and antimicrobial therapy consisting of vancomycin, amikacin, and ticarcillin for 10 days followed by vancomycin alone for an additional 10 days.
With evidence of progressive disease, his therapy was changed to idarubicin in conjunction with granulocyte colony-stimulating factor in February 1992. On the day prior to admission, the child developed a fever to 39°C and a blood culture was drawn from the central line before an infusion of packed erythrocytes and platelets. The child was not neutropenic at the time, and antimicrobial therapy was not initiated. The following day, gram-negative rods were isolated from both aerobic and anaerobic blood culture bottles (BACTEC Peds Plus and 7A media; Becton Dickinson Diagnostic Instrument Systems, Sparks, Md.) and the child was admitted for further evaluation.
At the time of admission, the child had a temperature of 36.8°C, heart rate of 119, respiratory rate of 28, and a blood pressure of 96/91. The child's lungs were clear to auscultation, and the central line insertion site showed no erythema or drainage. Erythema was observed over the child's face and scalp, but no other rashes or petechiae were noted. The child's leukocyte count at the time of admission was 8 x 109/liter with 5% bands, 43% segmented polymorphonuclear leukocytes, 39% lymphocytes, 11% monocytes, and 2% eosinophils. Four additional blood culture sets (one from each port of the central line and one from a peripheral venous site) were obtained prior to and 1 and 7 days after the administration of antimicrobial therapy consisting of vancomycin (13 mg/kg of body weight every 8 h), gentamicin (2.5 mg/kg every 8 h), and ticarcillin-clavulanate (75 mg/kg every 6 h). All blood cultures collected prior to and 1 day after initiating antimicrobial therapy (total of nine) exceeded the positive growth index threshold of the BACTEC 660NR within 24 h of incubation. An oxidase-positive, gram-negative rod was recovered from all positive bottles that produced highly mucoid colonies on MacConkey agar after 3 days of growth at 37°C (Fig. 1) . Upon continued incubation, the mucoid appearance of the colonies was gradually lost, suggestive of the activation or release of an exopolysaccharide depolymerase similar to mucoid strains ofPseudomonas aeruginosa (6 (14) demonstrated the following results: amikacin MIC = 8 p,g/ml, MBC = 16 ,ug/ml; gentamicin MIC = 4 ,g/ml, MBC = 8 ,ug/ml; trimethoprim and sulfamethoxazole MICs = 0.03 and 0.6 ,ug/ml, respectively, MBC = 4 and 80 ,ug/ml, respectively; ampicillin MIC = MBC = 1 jig/ml; cephalothin MIC = 2 ,ug/ml, MBC = 8 Fg/ml; cefotaxime MIC = MBC = 0.5 ,ug/ml; ceftazidime MIC = 8 ,ug/ml, MBC = 32 ,ug/ml; and piperacillin MIC = 8 ,ug/ml, MBC = 16 p,g/ml. By the Vitek System, the organism was also shown to be susceptible to ticarcillin (.16 ,ug/ml), imipenem (.4 p,g/ml), and ciprofloxacin (c0.5 p,g/ml) but resistant to aztreonam and chloramphenicol (232 ,ug/ml) by criteria for oxidase-positive organisms other than pseudomonads. On the basis of these findings and an uncomplicated course, vancomycin was discontinued from the therapeutic regimen and the child was discharged on the 8th hospital day but continued to receive parenteral antimicrobial therapy for 10 additional days.
To address the apparent association between infections caused by agrobacteria and biomedical implants, we evaluated the adhesive qualities of the mucoid strain and a nonmucoid strain ofA. radiobacter biovar 1 recovered from another source by using an in vitro model of adhesion (7) and biofilm formation (5) . No adhesion to or biofilm formation over the surface of polystyrene microtiter plates was de- plastic, the presence of a biomedical implant and/or immunosuppression appears to be a strong risk factor for the development of Agrobacterium infection in humans. The nature of the mucoid material is currently unknown, but studies have been initiated to determine its chemical composition.
Similar to coagulase-negative staphylococci, the prevalent use of implantable medical devices and immunosuppressive therapies will likely increase the frequency of isolation ofA. tumefaciens and A. radiobacter in the clinical microbiology laboratory.
We thank Alice Weissfeld for helpful comments and suggestions.
